New and Noteworthy

FMCT Funds Research into Hexokinase 2 Inhibitors at Johns Hopkins

FMCT Funds Research into Hexokinase 2 Inhibitors at Johns Hopkins

The Foundation for Metabolic Cancer Therapies has awarded a research grant to Dr. Peter Pedersen at John Hopkins School of Medicine. The research will focus on screening for Hexokinase 2 inhibitors. Hexokinase 2 …

Why the Name Change?

We have decided to change the name of our foundation from The Single Cause Single Cure Foundation, to The Foundation for Metabolic Cancer Therapies. We think this name better reflects our ethos. It was pointed out …

FMCT Supported Research Update: Case Study of Metabolically Supported Chemotherapy

FMCT Supported Research Update: Case Study of Metabolically Supported Chemotherapy

This important publication documents the full remission of a patient with stage 4, triple negative breast cancer. The protocol was designed and refined at Chemothermia Oncology Center in Istanbul Turkey. Dr. Slocum and …

Research Update

Research Update

In May of 2016 we awarded a substantial grant to Dr. Thomas Seyfried’s lab at Boston College. The grant is funding the exploration of a cocktail of metabolic therapies in a metastatic mouse model. The experiment …

Research Update

Research Update

The Foundation for Metabolic Cancer Therapies has funded a remarkable study combining oxaloacetate with various metabolic therapies. The results were so compelling that a larger and more comprehensive study was …